Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.85 USD | -2.12% |
|
-1.07% | +17.09% |
05-21 | LAVA Therapeutics N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-20 | LAVA Therapeutics N.V. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.09% | 49.69M | |
+17.09% | 45.34B | |
+42.10% | 40.42B | |
-9.70% | 37.92B | |
+33.28% | 31.75B | |
-8.98% | 27.71B | |
+13.37% | 26.52B | |
+44.11% | 13.96B | |
+32.33% | 12.44B | |
-7.26% | 11.26B |
- Stock Market
- Equities
- LVTX Stock
- News LAVA Therapeutics N.V.
- Transcript : LAVA Therapeutics N.V. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 10